How to Secure Wearable Device Data in Clinical Trials Using Encryption

The Rise of Wearables in Clinical Trials and the Need for Encryption

Wearables have transformed clinical trials by enabling real-time monitoring of physiological parameters such as heart rate, sleep patterns, glucose levels, and activity data. From wrist-worn devices to patches and smart garments, these sensors generate vast amounts of electronic source (eSource) data that flow continuously across wireless channels.

However, these data streams often contain sensitive patient information and must comply with privacy regulations such as HIPAA, GDPR, and ICH E6. Therefore, encrypting wearable data is no longer optional—it is a regulatory imperative. Failing to secure wearable data can lead to data breaches, protocol deviations, and regulatory findings during audits.

Common encryption requirements include:

• Securing Bluetooth Low Energy (BLE) transmissions from wearable to gateway
• Encrypting data in transit from gateway to cloud platform
• Storing wearable data in encrypted databases

Encryption Protocols for Wearable Data Streams

Multiple layers of encryption are needed to secure wearable-generated data across its lifecycle. The recommended protocols include:

• BLE Layer Encryption: AES-128 encryption at the hardware level using secure pairing (LE Secure Connections)
• Edge Gateway Transmission: TLS 1.3 or Datagram Transport Layer Security (DTLS) to transmit data to cloud
• Cloud Storage: AES-256 encryption at rest with granular access controls

For example, in a decentralized oncology trial, biometric patch data was transmitted via secure BLE to a smartphone app, which used end-to-end TLS encryption to forward data to the sponsor’s AWS-hosted CTMS platform.

Sample Table: Encryption Application Across Wearable Data Path

Validation of Encryption Protocols for Wearable Devices

Regulatory bodies such as the FDA and EMA expect encryption methods used in clinical trials—including those related to wearables—to be validated to ensure data confidentiality and system reliability.

Validation elements include:

• Device-level IQ/OQ: Ensures BLE encryption is functional across all firmware versions and wearable models
• App OQ/PQ: Validates data transmission encryption (TLS/DTLS) between app and back-end systems under various network conditions
• Cloud PQ: Tests encryption of at-rest data in multi-tenant environments

A case study from a wearable tech vendor showed how encryption validation was embedded into their QMS and referenced during sponsor and CRO audits.

SOPs and Training for Wearable Data Encryption Compliance

Organizations using wearables must draft SOPs specifically focused on encrypted data transmission. These SOPs should cover:

• BLE pairing procedures and data integrity verification
• Data routing workflows from edge to cloud
• Response procedures in case of encryption failure or device compromise

Training should include:

• Clinical staff awareness of how wearable encryption functions
• Site SOPs for wearable deployment and troubleshooting
• Periodic security refreshers for IT and data teams

You can find ready-to-use SOP frameworks at PharmaSOP aligned with GCP and ICH E6(R3) for wearable tech.

Key Management Strategies for Wearable Devices

Encryption is only as strong as the key management system behind it. For wearable ecosystems:

• Use cloud-native KMS (Key Management Services) with hardware-backed protection (e.g., AWS KMS, Google Cloud KMS)
• Ensure device-specific keys are rotated regularly and revoked when devices are decommissioned
• Implement policy-based access control (e.g., RBAC) to restrict key usage to authorized applications only

A CRO handling cardiology studies using wearable patches configured keys to auto-rotate every 30 days and integrated logs into their cloud audit trail.

Regulatory and Ethical Oversight of Wearable Data Security

Encrypting wearable data not only ensures regulatory compliance but also respects participant autonomy and informed consent. Ethics committees increasingly request:

• Clear encryption disclosures in ICFs
• Privacy notices explaining data handling and storage
• Provisions for data withdrawal and deletion upon participant request

Refer to FDA guidance on digital health technologies and ICH E6(R3) privacy principles for detailed expectations.

Real-World Example: Encrypted Wearable in Remote Heart Monitoring Study

In a phase II trial involving continuous ECG monitoring via wearable chest straps, the sponsor deployed:

• BLE encryption from device to patient smartphone
• TLS 1.2+ encryption between smartphone app and CTMS platform
• AES-256 at-rest encryption for cloud storage

The platform passed a sponsor audit with zero observations, and the wearable vendor received positive inspection feedback for encryption traceability.

Conclusion: Encryption as a Prerequisite for Safe and Compliant Wearable Integration

Wearables are redefining how data is collected and used in clinical trials. But their adoption must be paired with strong encryption and compliance strategies to ensure data security, patient trust, and regulatory success.

Sponsors, CROs, and vendors must collaborate to validate encryption systems, train users, and continuously monitor wearable data pipelines for vulnerabilities.

For SOP templates, validation checklists, and real-world case studies, explore PharmaValidation and stay updated with best practices from ICH.